Literature DB >> 12508306

Consensus criteria for the diagnosis of multifocal motor neuropathy.

Richard K Olney1, Richard A Lewis, Timothy D Putnam, Joseph V Campellone.   

Abstract

At this time, there are no widely accepted criteria for the diagnosis of multifocal motor neuropathy. Furthermore, there is insufficient empirical data to define clinical and laboratory features that may reliably separate certain lower motor neuron syndromes with overlapping features as distinct. The AAEM therefore developed five criteria through a formal consensus process that are described in this document to act as a guide for diagnosing multifocal motor neuropathy with a high level of confidence (definite multifocal motor neuropathy) or with a moderate level of confidence (probable motor neuropathy). In brief, the diagnosis requires clinical weakness without objective sensory loss or upper motor neuron signs in the distribution of two or more named nerves that is due to conduction block in two or more motor nerves outside of common entrapment sites. Furthermore, normal results are required for sensory nerve conduction studies.

Entities:  

Mesh:

Year:  2003        PMID: 12508306     DOI: 10.1002/mus.10317

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  25 in total

Review 1.  Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.

Authors:  Lotte Vlam; W-Ludo van der Pol; Elisabeth A Cats; Dirk C Straver; Sanneke Piepers; Hessel Franssen; Leonard H van den Berg
Journal:  Nat Rev Neurol       Date:  2011-11-22       Impact factor: 42.937

Review 2.  [Plasma exchange as a therapeutic option in neurological disorders].

Authors:  H C Lehmann; H P Hartung; G R Hetzel; B C Kieseier
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

Review 3.  Diagnostic investigation and multidisciplinary management in motor neuron disease.

Authors:  J A Rocha; C Reis; F Simões; J Fonseca; J Mendes Ribeiro
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

Review 4.  Subcutaneous immunoglobulin: opportunities and outlook.

Authors:  S Misbah; M H Sturzenegger; M Borte; R S Shapiro; R L Wasserman; M Berger; H D Ochs
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

Review 5.  Multifocal motor neuropathy: current therapies and novel strategies.

Authors:  Eduardo Nobile-Orazio; Francesca Gallia
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

6.  Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report.

Authors:  Patrizia Dacci; Nilo Riva; Marina Scarlato; Irmgard Andresen; Dirksteffen Schmidt; Giancarlo Comi; Raffaella Fazio
Journal:  Neurol Sci       Date:  2010-06-24       Impact factor: 3.307

Review 7.  Epidemiology of neuroimmunological diseases.

Authors:  Peter Flachenecker
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

8.  Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry.

Authors:  Martin Stangel; Ralf Gold; David Pittrow; Ulrich Baumann; Michael Borte; Maria Fasshauer; Manfred Hensel; Dörte Huscher; Marcel Reiser; Claudia Sommer
Journal:  Ther Adv Neurol Disord       Date:  2016-02-16       Impact factor: 6.570

9.  Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition?

Authors:  Emilien Delmont; Charles Benaïm; Mael Launay; Sabrina Sacconi; Marie-Hélène Soriani; Claude Desnuelle
Journal:  J Neurol       Date:  2009-07-30       Impact factor: 4.849

10.  Multifocal motor neuropathy with conduction block associated with metastatic lymphoma of the nervous system.

Authors:  Britta V Stern; Joachim M Baehring; Kleopas A Kleopa; Fred H Hochberg
Journal:  J Neurooncol       Date:  2006-05       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.